When was Cellix founded?

Cellix was founded in 2014 and raised its 1st funding round 4 years after it was founded.

Where is Cellix located?

Cellix is headquartered in Hyderabad, India. It is registered at BC-08 , Ground Floor,Block B, Indu Fortune Annexe, Phase 13, Kukatpally, KPHB Colony, Hyderabad, Tirumalagiri, Telangana, India, 500085.

Who is the current CEO of Cellix?

Mahesh Kandula of Cellix. They have also founded 1 company.

Which legal entities is Cellix associated with?

Cellix is associated with CELLIX BIO PRIVATE LIMITED and 1 other.

Is Cellix a funded company?

Cellix is a funded company, having raised a total of $4.64M across 5 funding rounds to date. The company's 1st funding round was a $***** Series A round, raised on Feb 06, 2018.

How much is Cellix worth?

The last known valuation of Cellix was $***** as of Jun 07, 2021.

When was the latest funding round of Cellix?

Cellix's latest funding was a $***** Angel round on Jun 07, 2021, with participation from 1 investor.

What is the annual revenue of Cellix?

Annual revenue of Cellix is ₹61.9K as on Mar 31, 2024.

Where does Cellix rank among its competitors?

Cellix ranks 1572nd amongst 3248 active competitors, of which 1138 are funded. It stands 11th in terms of total funding among its competitors. The most recent competitor to raise funding was C4 Therapeutics, which secured $25M in Jan, 2024.

Who are the top competitors of Cellix?

Cellix's top competitors include Jazz Pharmaceuticals, Sana Biotechnology and C4 Therapeutics. Among them, C4 Therapeutics secured the most recent funding round in January, 2024.

Cellix - 2026 Company Profile, Team, Funding, Competitors & Financials

Cellix is a deadpooled company based in Hyderabad (India), founded in 2014 by Mahesh Kandula. It operates as an AI-powered platform for drug discovery and development for various diseases. Cellix has raised $4.64M in funding from Total Clarity and V ClinBio, with last known valuation of $*****. The company has 3248 active competitors, including 1138 funded and 785 that have exited. Its top competitors include companies like Jazz Pharmaceuticals, Sana Biotechnology and C4 Therapeutics.

Company Details

AI-powered platform for drug discovery and development for various diseases. It has a proprietary platform Synergix AI that accelerates the drug discovery process by designing new molecular entities with synergistic pharmacological properties. It offers a diversified portfolio of drug candidates for the treatment of Neurological, Inflammatory and Metabolic Diseases.

Website: cellixbio.com
Registered Address: BC-08 , Ground Floor,Block B, Indu Fortune Annexe, Phase 13, Kukatpally, KPHB Colony, Hyderabad, Tirumalagiri, Telangana, India, 500085

Key Metrics

Founded Year

2014

Location

Hyderabad, India

Stage

Deadpooled

Total Funding

$4.64M in 5 rounds

Latest Funding Round

Angel, Jun 07, 2021, $*****

Last Known Valuation

$***** as on Jun 07, 2021

Investors

Total Clarity & 12 more

Ranked

1572^nd among 3248 active competitors

Annual Revenue

₹61.9K as on Mar 31, 2024

Similar Companies

Jazz Pharmaceuticals & 1166 more

View Cellix's full profile

Cellix is associated with 2 legal entities given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Documents
CELLIX BIO PHARMA PRIVATE LIMITED CIN: U73100TG2020PTC138576 , India, Active	Jan 21, 2020	$0 (As on Mar 31, 2024)	-
CELLIX BIO PRIVATE LIMITED CIN: U74900TG2014PTC094095 , India, Active	May 21, 2014	$748 (As on Mar 31, 2024)	-

Cellix has raised a total funding of $4.64M over 5 rounds. Its first funding round was on Feb 06, 2018. Its latest funding round was a Angel round on Jun 07, 2021 for $*****. 1 investor participated in its latest round. Cellix has 6 institutional investors and 7 angel investors.

Here is the list of recent funding rounds of Cellix:

Filter this list

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Jun 07, 2021	6512622	Angel	8367906	9740639	7439430	4167765
Aug 28, 2020	3933321	Series A	7788904	2906660	6284997	Mark Werner Messow
May 06, 2019	1604751	Angel	5344231	2175115	Chandra Shekhar Shastri	Deepak Maheshwari & 3 more

Access funding benchmarks and valuations. Sign up today!

View details of Cellix's funding rounds and investors

The founders of Cellix is Mahesh Kandula. Mahesh Kandula is the CEO of Cellix.

Here are the details of Cellix's key team members:

Mahesh Kandula: Founder & CEO of Cellix. They serve on the board of 1 company.

Cellix's Board of Directors

Cellix's board has 3 active members. Mahesh Kandula, Subramaniam Apparsundaram and Achanna Chowdary Valluri are part of team.

Here is the list of Cellix's board of directors:

Name	Type	Representing	Status	Duration
Achanna Chowdary Valluri	Team	-	Current	11y 10m
{imfxhn	Team	-	Past	5y 1m
qalarmf	Team	-	Past	7y 4m
ergz{tk	Team	-	Past	6y 6m
Subramaniam Apparsundaram	Investor	VClinBio	Current	8y 5m

View details of Cellix's Founder profiles and Board Members

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Cellix include Jazz Pharmaceuticals, Sana Biotechnology and C4 Therapeutics. Here is the list of Top 10 competitors of Cellix, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Jazz Pharmaceuticals 2003, Dublin (Ireland), Public	Developer of novel biopharmaceutical medicines for unmet medical needs	$265M	Versant Ventures, Prospect Venture Partners ... & 14 others	82/100
2nd	Sana Biotechnology 2018, Seattle (United States), Public	Developer of genetically engineered cell therapies for multiple disorders	$821M	Bezos Expeditions, F-Prime Capital & 17 others	75/100
3rd	C4 Therapeutics 2016, Cambridge (United States), Public	Developer of small molecule drugs for treating cancer	$223M	Cobro Ventures, Perceptive Advisors & 27 others	74/100
4th	Juno Therapeutics 2013, Seattle (United States), Acquired	Global biopharmaceutical company discovering, developing, and delivering innovative medicines	$317M	RA Capital Management, BB Biotech & 14 others	74/100
5th	Blueprint Medicines 2008, Cambridge (United States), Acquired	Developer of selective kinase inhibitors for patients with genomically defined cancers	$115M	Third Rock Ventures, Nextech Invest & 20 others	72/100
6th	Kronos Bio 2017, San Mateo (United States), Acquired	Developer of small molecule based therapeutics for cancer treatment	$271M	Omega Funds, Vida Ventures & 18 others	72/100
7th	Pacira 2006, Parsippany Troy Hills (United States), Public	Developer of injectable non-opioid products for post-surgical pain control	$85M	Orbimed, HBM Healthcare Investments & 6 others	72/100
8th	Recursion Pharmaceuticals 2013, New York (United States), Public	AI-enabled drug discovery and development platform for novel therapeutics	$452M	Baillie Gifford, Felicis Ventures & 46 others	72/100
9th	MacroGenics 2000, Rockville (United States), Public	Developer of novel biologics for the treatment of autoimmune disorders, cancer and infectious disease	$126M	Nextech Venture, Ventures West & 29 others	72/100
10th	ADMA Biologics 2005, Ramsey (United States), Public	Biopharmaceutical company innovating plasma-derived therapeutics for immune deficiencies and infectious diseases	$17.6M	Aisling Capital, Burrill and Company & 4 others	71/100
1572nd	Cellix 2014, Hyderabad (India), Deadpooled	AI-powered platform for drug discovery and development for various diseases	$4.64M	BDS Trust, VClinBio & 11 others	33/100

Get insights and benchmarks for competitors of 2M+ companies! Sign up today!

Looking for more details on Cellix's competitors? Click here to see the top ones

Founders (largest shareholder) own 52.16%, Parent Entities own 44.51%, Enterprises own 0.27% and Angels own 3.00%. The net worth of Cellix's founders is INR 715Cr as of Jun 07, 2021.

Shareholders Name	Post Round Holding %	Net worth	Cumulative Investment	Realised Returns	Unrealised Returns	Return Multiple
Founder	52.16%	715Cr	3777538	6024734	4992541	4771796
Mahesh Kandula	2841217	3032252	8263699	3040294	1387233	6325694
Parent Entity	44.51%	610Cr	5938395	7737450	1488386	9679555
Enterprise	0.27%	3.7Cr	0	0	0	0
Angel	3.00%	41.2Cr	352	741	774	878
Jan Pieter Werkman	0	0	0	0	0	0
Deepak Maheshwari	5	6	5	7	8	1
Paresh Dattatraya Sukthankar	0	0	0	0	0	0
Chandra Shekhar Shastri	0	0	0	0	0	0
Mark Werner Messow	0	0	0	0	0	0
Other People	0.05%	65.9L	0	0	0	0
Total	99.99%	1,370Cr	5047827	7639891	5551579	9946959